Rohan Paul· @rohanpaul_ai · X·· 3 小时前AI 评分56
AI 导读
Intology 的自动化研究系统 Locus 自主开发出科学 AI 模型,在分子性质预测、微调 Boltz-2 预测小分子效价以及基于 BoltzGen、Boltz-2、ESMC、ESMFold2 构建抗体设计流程等任务上表现优于 SOTA 专家方案。Locus 会提出实验、在 GPU 上并行运行多批实验并保留有效结果迭代,在数据有限时泛化更好、样本效率更高、解空间更多样。Rohan Paul 称其在分子预测上击败了 GPT-6 Astra 和 Claude Opus 5.5 智能体。
正文
An AI system just designed better molecular models than the specialist tools built by the labs that own those models.
@intology’s Locus does a machine-learning researcher’s job:
> proposes experiments,
> runs many batches of them in parallel on GPUs
> keeps what works and repeats,
> now applied to drug and antibody design.
Locus beat GPT-6 Astra and Claude Opus 5.5 agents on molecular prediction
Locus sets the frontier for automating molecular design Our automated research system Locus develops scientific AI models that outperform SOTA expert solutions Unlocking the potential of scientific AI requires leveraging proprietary data. Locus achieves this autonomously 🧵👇 -- We test Locus across a number of tasks related to molecular scoring and design: training molecular property prediction models for a proprietary task, fine-tuning Boltz-2 to predict small-molecule potency, and building antibody design workflows around BoltzGen, Boltz-2, ESMC, and ESMFold2. Each of these settings are real-world AI for science use cases, where tasks are often out-of-distribution for existing foundation models and limited in data, while featuring expensive and noisy evaluators. Compared to state-of-the-art baselines and LLM agents set to optimize these tasks, Locus achieves higher performance. Additionally, Locus generalizes better despite limited data, finds more sample efficient solutions, and explores a higher diversity of solutions.在 X 查看被引用的帖子
来源:Rohan Paul · x.com